No more gruesome needle pricks to monitor blood sugar levels. New research reveals that natural glucose fluctuations, tracked ...

Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...

1 Department of Pharmacy, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China 2 Department of Pharmacy, The First Hospital of Changsha, ...

These include: insulin vials and syringes (though rarely used now); re-useable insulin pens with insulin cartridges; and disposable prefilled pens. A major complication of poor injection technique ...

BEIJING, Apr 23 (APP): The insulin glargine cartridge by Gan & Lee Pharmaceuticals just obtained the first biosimilar approval from the Drug Regulatory Authority of Pakistan (DRAP), a move expected to ...

ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has approved the insulin glargine cartridge developed by China’s Gan & Lee Pharmaceuticals, marking the first biosimilar of its kind ...

Four years after launching a plan to revitalize Calgary’s struggling downtown, the city reports signs of progress — from increased transit ridership and property values, to a drop in social ...

An investigation by the health system, FDA and other regulatory agencies revealed a former nurse reused needleless syringes while administering IV medications — a violation of hospital policy ...

Therefore, the tariff rate adds up to: 0% Base tariff + 20% Fentanyl tariff = 20% Total tariff rate Syringes and needles have been subject to some of the highest tariff rates, targeted by both the ...

Sanofi has of late been making brisk moves in India. Last year, it launched Soliqua, a mix of insulin glargine and lixisenatide, a drug that mimics the GLP-1 hormone to help control sugar and lose ...

Several sensitivity checks ensured results weren’t influenced by other insulin products or outlier states. The study included 487,281 insulin glargine prescription fills (mean age, 49.5 years; male, ...

or insulin glargine for 40 or 52 weeks. In this post hoc analysis, the researchers assessed patients (N=6246) with T2D for the time of maintaining glycated hemoglobin (HbA 1c) below 7.0% while ...